CARAMEL study: Clinical prognostic biomarkers for ipilimumab-related outcome in metastatic melanoma patients.

Madeddu, C;Pani, F;Massa, E;Scartozzi, M
2016-01-01
2016
Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie